ArQule prostate cancer drug candidate successful in Phase 2
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 9:19AM CST
ARQL: 1.15 (+0.01)
Ad Comm approaches for Daiichi Sankyo anticoagulant
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 12:49PM CDT
The Next Biotech Buyout Stock
Motley Fool Staff - Motley Fool - Fri Oct 10, 7:15AM CDT
Biotech stocks are notoriously volatile, making them best suited for only the most risk-tolerant investors. But for those willing to take the risk, biotech companies can often make a big splash; particularly when a bigger fish gobbles them up....
JNJ: 104.59 (+0.31), PTLA: 28.35 (+0.21), PFE: 31.42 (-0.03), BMY: 59.15 (-0.01), PRTA: 20.14 (+1.41), PBYI: 189.96 (+0.12)